✦ LIBER ✦

The dexamethasone suppression test in depressive and schizophrenic patients under controlled treatment conditions

✍ Scribed by H. J. Möller; W. Kissling; P. Bottermann

Publisher: Springer-Verlag
Year: 1986
Tongue: English
Weight: 645 KB
Volume: 235
Category: Article
ISSN: 1433-8491
DOI: 10.1007/bf00515912

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The performance of brain-damaged and sch

The performance of brain-damaged and schizophrenic patients on the Minnesota Percepto-Diagnostic Test under standard and BIP conditions of administration

✍ Terrill R. Holland; Helen M. Wadsworth; Fred L. Royer 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB 👁 2 views

PROBLEM Canter

Cianopramine and amitriptyline in the tr

Cianopramine and amitriptyline in the treatment of depressed patients — a placebo-controlled study

✍ L. Hormazabal; L. M. O. Omer; S. Ismail 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 330 KB

3-Cyano-imipramine (cianopramine) is a potent and selective inhibitor of serotonin uptake into synaptosomes. In a double-blind trial, 60 patients with various types of depression fulfilling the DSM-III criteria of depressive episodes were treated with either cianopramine (n=20, mean daily dose 3.3\_

How long should a trial of escitalopram

How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database

✍ David S. Baldwin; Dan J. Stein; Ornah T. Dolberg; Borwin Bandelow 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## Objective To extend the knowledge of course of improvement in patients with major depressive disorder (MDD), social anxiety disorder (SAD) or generalised anxiety disorder (GAD) participating in randomised placebo‐controlled trials (RCTs) and to infer the optimal duration of initial